R2 Hemostasis Diagnostics India Private Limited, a active foreign private limited company, was established on 15 September 2010 in Ghaziabad, Uttar Pradesh, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74992UP2010FTC041987. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.94 M.
It upholds a compliant status. Its leadership includes Sumit Agarwal (Director), Michael Joseph Morris (Director), Daniel J Smogor (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ff - 26, Omaxe Park Plaza Indirapuram,Shakti Khand-2, Ghaziabad, Uttar Pradesh, 201010.
U74992UP2010FTC041987
041987
15 September 2010
₹1.00 Cr
₹7.94 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into R2 Hemostasis Diagnostics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Agarwal | Director | 24 Dec 2014 | Current |
| Michael Joseph Morris | Director | 15 Sep 2010 | Current |
| Daniel J Smogor | Director | 15 Sep 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
R2 Hemostasis Diagnostics India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.33% decrease. The company also saw a substantial fall in profitability, with a 98.03% decrease in profit. The company's net worth moved up by a moderate rise of 0.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, R2 Hemostasis Diagnostics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with R2 Hemostasis Diagnostics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of R2 Hemostasis Diagnostics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R2 Hemostasis Diagnostics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
R2 Hemostasis Diagnostics India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
R2 Hemostasis Diagnostics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
The activity Sumit Agarwal was appointed as a Director was appointed as a Director on 24 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
The activity Michael Joseph Morris was appointed as a Director was appointed as a Director on 15 Sep 2010 & has been associated with this company since 15 years 2 months . was completed.
Daniel J Smogor was appointed as a Director was appointed as a Director on 15 Sep 2010 & has been associated with this company since 15 years 2 months . was recorded as a recent event.
R2 Hemostasis Diagnostics India Private Limited was registered on 15 Sep 2010 with Roc Kanpur & aged 15 years 2 months as per MCA records. was recorded as a recent event.
The CIN of R2 Hemostasis Diagnostics India Private Limited is U74992UP2010FTC041987.
R2 Hemostasis Diagnostics India Private Limited is headquartered at Ff - 26, Omaxe Park Plaza Indirapuram,Shakti Khand-2, Ghaziabad, Uttar Pradesh, 201010.
R2 Hemostasis Diagnostics India Private Limited was incorporated on 15 September 2010.
The current directors of R2 Hemostasis Diagnostics India Private Limited are
The primary industry of R2 Hemostasis Diagnostics India Private Limited is Trade.
R2 Hemostasis Diagnostics India Private Limited is unlisted.
The authorized capital of R2 Hemostasis Diagnostics India Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.94 M.
The compliance status of R2 Hemostasis Diagnostics India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX